These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16123048)

  • 1. Ezetimibe coadministered with fenofibrate: some safety questions.
    Borja J
    Eur Heart J; 2005 Nov; 26(21):2344; author reply 2344. PubMed ID: 16123048
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and efficacy of long-term co-administration of fenofibrate and ezetimibe in patients with mixed hyperlipidemia.
    McKenney JM; Farnier M; Lo KW; Bays HE; Perevozkaya I; Carlson G; Davies MJ; Mitchel YB; Gumbiner B
    J Am Coll Cardiol; 2006 Apr; 47(8):1584-7. PubMed ID: 16630994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of alanine transaminase and creatine kinase elevations with the use of ezetimibe in an ambulatory care setting.
    McGinnis B; Schimmer J; Hutka K
    J Clin Lipidol; 2010; 4(6):501-7. PubMed ID: 21122697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezetimibe/simvastatin (INEGY) in the treatment of hyperlipidaemia.
    Kastelein JJ; Sankatsing RR
    Int J Clin Pract; 2005 Dec; 59(12):1464-71. PubMed ID: 16351680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of the coadministration of ezetimibe/simvastatin with fenofibrate in patients with mixed hyperlipidemia.
    Farnier M; Roth E; Gil-Extremera B; Mendez GF; Macdonell G; Hamlin C; Perevozskaya I; Davies MJ; Kush D; Mitchel YB;
    Am Heart J; 2007 Feb; 153(2):335.e1-8. PubMed ID: 17239698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter by Westerink and Visseren regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation".
    Westerink J; Visseren FL
    Circulation; 2009 Sep; 120(9):e66; author reply e69-70. PubMed ID: 19720942
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter by Settergren et al regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation".
    Settergren M; Rydén L; Pernow J
    Circulation; 2009 Sep; 120(9):e68; author reply e69-70. PubMed ID: 19720944
    [No Abstract]   [Full Text] [Related]  

  • 8. Ezetimibe in the treatment of uncontrolled hyperlipidemia in kidney transplant patients.
    Rodríguez-Ferrero ML; Anaya F
    Transplant Proc; 2008 Dec; 40(10):3492-5. PubMed ID: 19100421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter by Tershakovec et al regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation".
    Tershakovec AM; Veltri EP; Pasternak RC
    Circulation; 2009 Sep; 120(9):e67; author reply e69-70. PubMed ID: 19720943
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of mixed hyperlipidaemia.
    Stalenhoef AF
    Eur Heart J; 2005 May; 26(9):856-7. PubMed ID: 15781431
    [No Abstract]   [Full Text] [Related]  

  • 11. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
    Hou R; Goldberg AC
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Setting a new standard in achieving superior efficacy: ezetimibe + simvastatin.
    Farnier M
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():27-8. PubMed ID: 18001317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the potential for pharmacokinetic interaction between fenofibrate and ezetimibe: A phase I, open-label, multiple-dose, three-period crossover study in healthy subjects.
    Gustavson LE; Schweitzer SM; Burt DA; Achari R; Rieser MJ; Edeki T; Chira T; Yannicelli HD; Kelly MT
    Clin Ther; 2006 Mar; 28(3):373-87. PubMed ID: 16750452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antilipidemic effects of ezetimibe in patients with diabetes.
    Stroup JS; Kane MP; Busch RS
    Diabetes Care; 2003 Oct; 26(10):2958-9. PubMed ID: 14514611
    [No Abstract]   [Full Text] [Related]  

  • 15. Ezetimibe--an update.
    Drug Ther Bull; 2009 Aug; 47(8):91-5. PubMed ID: 19654419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comment: supratherapeutic response to ezetimibe administered with cyclosporine.
    Ito MK
    Ann Pharmacother; 2005 Dec; 39(12):2141; author reply 2142. PubMed ID: 16288059
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
    Catapano AL; Davidson MH; Ballantyne CM; Brady WE; Gazzara RA; Tomassini JE; Tershakovec AM
    Curr Med Res Opin; 2006 Oct; 22(10):2041-53. PubMed ID: 17022864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin or fenofibrate on post-prandial lipaemia in type 2 diabetic patients with hyperlipidaemia.
    Iovine C; Lilli S; Gentile A; Patti L; Di Marino L; Cipriano P; Riccardi G; Rivellese AA
    Eur J Clin Invest; 2006 Aug; 36(8):560-5. PubMed ID: 16893378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ezetimibe revisited.
    Med Lett Drugs Ther; 2008 Aug; 50(1293):67-8. PubMed ID: 18719525
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination therapy of low-dose atorvastatin and fenofibrate in mixed hyperlipidemia.
    Chatley P; Badyal DK; Calton R; Khosla PP
    Methods Find Exp Clin Pharmacol; 2007 Apr; 29(3):217-21. PubMed ID: 17520105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.